How will HPV vaccines affect cervical cancer?

Nature Reviews. Cancer
R B Roden, T-C Wu

Abstract

Cancer of the uterine cervix is the second largest cause of cancer deaths in women, and its toll is greatest in populations that lack screening programmes to detect precursor lesions. Persistent infection with 'high risk' genotypes of human papillomavirus (HPV) is necessary, although not sufficient, to cause cervical carcinoma. Therefore, HPV vaccination provides an opportunity to profoundly affect cervical cancer incidence worldwide. A recently licensed HPV subunit vaccine protects women from a high proportion of precursor lesions of cervical carcinoma and most genital warts. Here we examine the ramifications and remaining questions that surround preventive HPV vaccines.

References

Feb 1, 1975·Infection and Immunity·E J Chipperfield, B A Evans
Dec 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·R KirnbauerJ T Schiller
Jul 1, 1990·Journal of Virology·N D Christensen, J W Kreider
May 11, 1991·Obstetrics and Gynecology·R J KurmanD Solomon
Feb 1, 1991·Obstetrics and Gynecology·J R BrumstedT Reed
Jun 1, 1972·The Journal of Investigative Dermatology·L D Koller, C Olson
Jun 1, 1980·Virology·I DvoretzkyD R Lowy
Nov 1, 1994·Journal of Virology·R B RodenJ T Schiller
Jan 1, 1994·Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology·J A BellR Schlegel
Jan 1, 1994·Intervirology·L T Chow, T R Broker
Jan 1, 1994·Intervirology·J L Brandsma
Nov 1, 1994·Journal of Virology·R B RodenJ T Schiller
Jun 1, 1993·The Journal of General Virology·M S CampoW F Jarrett
Dec 5, 1995·Proceedings of the National Academy of Sciences of the United States of America·J A SuzichR Schlegel
Sep 1, 1995·Current Opinion in Oncology·J Palefsky
Jul 21, 1997·Virology·M MüllerL Gissmann
Feb 12, 1998·The New England Journal of Medicine·G Y HoR D Burk
Mar 21, 1998·Proceedings of the National Academy of Sciences of the United States of America·H L GreenstoneJ T Schiller
Mar 24, 1999·Journal of the National Cancer Institute·E L FrancoL L Villa
Aug 19, 1999·The Journal of Pathology·J M WalboomersN Muñoz

❮ Previous
Next ❯

Citations

Apr 9, 2008·Journal of Biomedical Science·Annie A WuSara I Pai
Jan 13, 2010·Immunologic Research·Ken LinT-C Wu
Apr 1, 2008·Journal of Biosciences·Cheryl M TravassoChandan Kumar-Sinha
Apr 5, 2008·Transactions of the Royal Society of Tropical Medicine and Hygiene·A C AnsinkN R van den Broek
Dec 28, 2007·Experimental & Molecular Medicine·Chien-Fu HungT-C Wu
May 8, 2009·Immunology and Cell Biology·Balasubramanyam KaranamRichard B S Roden
Dec 23, 2006·Nature Reviews. Cancer·Ciaran B J WoodmanLawrence S Young
Feb 16, 2007·Nature Reviews. Cancer·Mel Greaves
Nov 24, 2007·Nature Reviews. Cancer·Dominik Duelli, Yuri Lazebnik
Jan 5, 2007·Immunology and Cell Biology·Gunasegaran Karupiah, Geeta Chaudhri
Nov 11, 2009·Proceedings of the National Academy of Sciences of the United States of America·Sang-Hyuk Chung, Paul F Lambert
Dec 2, 2008·Journal of Psychosocial Oncology·Bruce W SmithKathy B Baumgartner
Jun 3, 2008·The Journal of Infectious Diseases·Oliver P GüntherBabak Pourbohloul
May 28, 2009·Journal of the National Cancer Institute·Subhashini JaguRichard B S Roden
Mar 19, 2013·Journal of the National Cancer Institute·Devasena AnantharamanPaul Brennan
Jan 16, 2009·The American Journal of Surgical Pathology·Wilko WeichertIver Petersen
Nov 14, 2008·Southern Medical Journal·Kimiko L IshibashiLainie Friedman Ross
Oct 12, 2007·Journal of Virology·Ratish GambhiraRichard B S Roden
Nov 13, 2009·Journal of Virology·M Saveria Campo, Richard B S Roden
Mar 29, 2013·Journal of Virology·Subhashini JaguRichard B S Roden
May 23, 2007·Molekuliarnaia biologiia·S A Nedospasov, D V Kuprash
Apr 18, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Shiwen PengT-C Wu
Jan 17, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Zhenhua LinRichard B S Roden
Aug 29, 2012·Cancer Prevention Research·Mark C PierceRebecca Richards-Kortum
Nov 26, 2008·BMC Biochemistry·Sylvie Beaudenon, Jon M Huibregtse
Aug 28, 2007·BMC Cancer·Vincent Vinh-HungAnne-Thérèse Vlastos
Jul 19, 2008·Journal of Carcinogenesis·Bernice L Robinson-BennettJohn Papaconstantinou
Oct 29, 2010·Journal of Translational Medicine·Luciano Mariani, Aldo Venuti
Oct 29, 2009·Virology Journal·Ratish GambhiraRichard Roden
Aug 21, 2010·Virology Journal·William T SeamanJennifer Webster-Cyriaque
May 26, 2010·Infectious Agents and Cancer·Valeria BergonziniGiorgio Palù
Feb 6, 2013·PloS One·Subhashini JaguRichard B S Roden
Mar 1, 2008·Biologics : Targets & Therapy·Archana MonieT-C Wu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.